Farmacogenética, Genética del Cáncer, Polimorfismos Genéticos y Farmacoepidemiología
Universidad Europea Miguel de Cervantes
Valladolid, EspañaPublicaciones en colaboración con investigadores/as de Universidad Europea Miguel de Cervantes (5)
2021
-
A cross-sectional study of psychotropic drug use in the elderly: Consuming patterns, risk factors and potentially inappropriate use
European Journal of Hospital Pharmacy, Vol. 28, Núm. 2, pp. 88-93
-
Association of CNR1 and INSIG2 polymorphisms with antipsychotics-induced weight gain: a prospective nested case–control study
Scientific Reports, Vol. 11, Núm. 1
2018
-
A polypharmacy risk prediction model for elderly patients based on sociodemographic and clinical factors
International Journal of Clinical Pharmacology and Therapeutics, Vol. 56, Núm. 12, pp. 577-584
2017
-
Exercise Intervention in Pediatric Patients with Solid Tumors: The Physical Activity in Pediatric Cancer Trial
Medicine and Science in Sports and Exercise, Vol. 49, Núm. 2, pp. 223-230
2014
-
ACTN3 R577X polymorphism and explosive leg-muscle power in elite basketball players
International Journal of Sports Physiology and Performance, Vol. 9, Núm. 2, pp. 226-232